logo-regularlogo-regularlogo-regularlogo-regular
  • Home
  • About Us
    • Historical Background
    • Who We Are
    • What We Stand For
    • Core Objectives
    • Governance Structure
    • Who We Work With
    • Partners
  • What We Do
    • Leadership Programmes
      • INELI-SSAf
        • Background
        • Classroom
        • Training & Capacity Building Committee
      • IYALI
      • AfLAC
    • Support AfLIA
  • Membership
    • Membership Subscription
    • Membership Fee
    • Membership Application
      • Associations and Institutions
      • Individuals
    • Membership Database
    • Membership Benefits
  • Africa LIBS/LAs
    • Libraries
      • Academic Libraries
      • Community Libraries
      • Libraries in the Diaspora
      • National Libraries
      • Parliamentary Libraries
      • Public Libraries
      • Research Libraries
      • School Libraries
      • Special Libraries
    • Library Associations
      • National Library Associations
      • National Library Consortia
      • Regional Library Associations
    • Other
      • Corporate Members
      • Information & Documentation Centers
      • Library & Information-Related Business
      • Library & Non-Profit Organisations
      • Library & Information Education/Training Institutions
      • Registration Councils
  • News & Events
    • News
    • Conferences
    • Blog
    • Media
      • Gallery
      • Videos
  • Resources
    • Webinars
    • Conference Proceedings
    • Wikipedia Course
  • Publications
    • AfLIA Constitution
    • AfLIA Strategic Plan
    • Annual Reports
    • Statements, Declarations & Reports
  • Contact us

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Share

About us

Historical Background
Who We Are
What We Stand For
Core Objectives
Governance Structure
Who We Work With
Partners

What we do

INELI-SSAf
IYALI
AfLAc

Membership

Be a member
Renew membership
AfLIA Membership Database

Africa LIBS/LAs

Libraries
Library Associations
Other

News & Events

News
Blog
Conferences
Webinars
Publications
Gallery
Videos

Publications

AfLIA Strategic Plan
Annual Reports
Statements

Follow us

AfLIA on Facebook
AfLIA on Twitter
AfLIA on Youtube
Public Libraries Network on Facebook
INELI-SSAf on Facebook
Subscribe To Our Newsletter
© 2023 African Library & Information Associations & Institutions. All Rights Reserved.